Hepatitis e

Current Opinion in Infectious Diseases

Volumn 26, Issue 5, 2013, Pages 471-478

  Dalton, Harry R ^a,b   Hunter, Jeremy G ^a   Bendall, Richard P ^a,b  

^a ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

blood products; cirrhosis; epidemiology; hepatitis E; zoonosis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; RIBAVIRIN;

BLOOD TRANSFUSION; CHRONIC LIVER DISEASE; CLINICAL FEATURE; DEVELOPING COUNTRY; GENOTYPE; GRAFT RECIPIENT; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; INCIDENCE; LIVER FAILURE; LIVER FUNCTION TEST; MATERNAL MORTALITY; MONOTHERAPY; NEUROLOGIC DISEASE; PREGNANT WOMAN; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; TREATMENT DURATION;

ANIMALS; CHRONIC DISEASE; HEPATITIS E; HUMANS; LIVER CIRRHOSIS; SWINE; ZOONOSES;

EID: 84883600482     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/01.qco.0000433308.83029.97     Document Type: Review

References (58)

1. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012; 379:2477-2488.
2. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8:698-709.
3. Labrique AB, Sikder SS, Krain LJ, et al. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 2012; 18:1401-1404.
4. Dalton HR, Hazeldine S, Banks M, et al. Locally acquired hepatitis E in chronic liver disease. Lancet 2007; 369:1260.
5. Kumar Acharya S, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007; 46:387-394.
6. Rein DB, Stevens GA, Theaker J, et al. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012; 55:988-997.
7. Passos AM, Heringer TP, Medina-Pestana JO, et al. First report and molecular characterization of hepatitis E virus infection in renal transplant recipients in Brazil. J Med Virol 2013; 85:615-619.
8. Purdy MA, Dell'Amico MC, Gonzales JL, et al. Human and porcine hepatitis E viruses, southeastern Bolivia. Emerg Infect Dis 2012; 18:339-340.
9. Mirazo S, Ramos N, Russi JC, Arbiza J. Genetic heterogeneity and subtyping of human hepatitis E virus isolates from Uruguay. Virus Res 2013; 173:364-370.
10. Garća CG, Sánchez D, Villalba MC, et al. Molecular characterization of hepatitis E virus in patients with acute hepatitis in Venezuela. J Med Virol 2012; 84:1025-1029.
11. Gardinali NR, Barry AF, Otonel RA, et al. Hepatitis E virus in liver and bile samples from slaughtered pigs of Brazil. Mem Inst Oswaldo Cruz 2012; 107:935-939.
12. Teo C-G. Fatal outbreaks of jaundice in pregnancy and the epidemic history of HEV. Epidemiol Infect 2012; 140:767-787.
13. Backer JA, Berto A, McCreary C, et al. Transmission dynamics of hepatitis E virus in pigs: estimation from field data and effect of vaccination. Epidemics 2012; 4:86-92.
14. Purcell RH, Engle RE, Rood MP, et al. Hepatitis E virus in rats, Los Angeles, California, USA. Emerg Infect Dis 2011; 17:2216-2222.
15. Izopet J, Dubois M, Bertagnoli S, et al. Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France. Emerg Infect Dis 2012; 18:1274-1281.
16. Berto A, Martelli F, Grierson S, Banks M. Hepatitis E virus in pork food chain United Kingdom. Emerg Infect Dis 2012; 18:1358-1360.
17. Barnaud E, Rogée S, Garry P, et al. Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food. Appl Environ Microbiol 2012; 78:5153-5159.
18. Mansuy JM, Bendall R, Legrand-Abravanel F, et al. Hepatitis E virus antibody in blood donors, France. Emerg Infect Dis 2011; 17:2309-2312.
19. Ishida S, Yoshizumi S, Ikeda T, et al. Detection and molecular characterization of hepatitis E virus in clinical, environmental and putative animal sources. Arch Virol 2012; 157:2363-2368.
20. Crossan C, Baker PJ, Craft J, et al. Hepatitis E virus genotype 3 in shellfish, United Kingdom. Emerg Infect Dis 2012; 18:2085-2087.
21. Donia D, Dell'Amico MC, Petrinca AR, et al. Presence of hepatitis E RNA in mussels used as bio-monitors of viral marine pollution. J Virol Methods 2012; 186:198-202.
22. Brassard J, Gagne MJ, Genereux M, Cote C. Detection of human food-borne and zoonotic viruses on irrigated, field-grown strawberries. Appl Environ Microbiol 2012; 78:3763-3766.
23. Madden RG, Hunter JG, Stone AM, et al. Locally acquired hepatitis E. Geographical clustering and environmental factors: a nested case control study. J Hepatol 2012; 56 (Suppl 2):s64.
24. Wenzel JJ, Preiss J, Schemmerer M, et al. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013; 207:497-500.
25. Faramawi MF, Johnson E, Chen S, Pannala PR. The incidence of hepatitis E virus infection in the general population of the USA. Epidemiol Infect 2011; 139:1145-1150.
26. Beale MA, Tettmar K, Szypulska R, et al. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang 2011; 100:340-342.
27. http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/HepatitisE/ Surveillance/. [Accessed 21 March 2013]
28. Drobeniuc J, Greene-Montfort T, Le NT, et al. Laboratory-based surveillance for hepatitis E virus infection United States. Emerg Infect Dis 2013; 19:218-222.
29. Dalton HR, Bendall RP, Rashid M, et al. Host risk factors and autochthonous hepatitis E infection. Eur J Gastroenterol Hepatol 2011; 23:1200-1205.
30. Dalton HR, Fellows HJ, Stableforth W, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007; 26:1429-1435.
31. Vine LJ, Shepherd K, Hunter JG, et al. Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis. Aliment Pharmacol Ther 2012; 36:16-21.
32. Donaghy L, Barry F, Hunter JG, et al. Clinical and laboratory features and natural history of seronegative hepatitis in a nontransplant centre. Eur J Gastroenterol Hepatol 2013. [Epub ahead of print]. A large series showing acute hepatitis E is the commonest cause of viral hepatitis.
33. Colson P, Romanet P, Moal V, et al. Autochthonous infections with hepatitis E virus genotype 4, France. Emerg Infect Dis 2012; 18:1361-1364.
34. Garbuglia AR, Scognamiglio P, Petrosillo N, et al. Hepatitis E virus genotype 4 outbreak Italy. Emerg Infect Dis 2013; 19:110-114.
35. Anty R, Ollier L, Pé ron JM, et al. First case report of an acute genotype 3 hepatitis E infected pregnant woman living in South-Eastern France. J Clin Virol 2012; 54:76-78.
36. Lhomme S, Abravanel F, Dubois M, et al. Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients. J Virol 2012; 86:10006-10014.
37. Pas SD, de Man RA, Mulders C, et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012; 18:869-872.
38. Koning L, Pas SD, de Man RA, et al. Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant 2013; 32:78-85.
39. Riezebos-Brilman A, Puchhammer-Stö ckl E, van der Weide HY, et al. Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant 2013; 32:341-346.
40. Moal V, Legris T, Burtey S, et al. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol 2013; 85:462-471.
41. Halac U, Bé land K, Lapierre P, et al. Chronic hepatitis E infection in children with liver transplantation. Gut 2012; 61:597-603.
42. Motte A, Roquelaure B, Galambrun C, et al. Hepatitis E in three immunocompromized children in southeastern France. J Clin Virol 2012; 53:162-166.
43. Pischke S, Steifel P, Franz B, et al. Chronic hepatitis E in heart transplant patients. Am J Transplant 2012; 12:3128-3133.
44. Naik A, Gupta N, Goel D, et al. Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J Viral Hepat 2013; 20:e138-e140.
45. Shah SA, Lal A, Idrees M, et al. Hepatitis E virus-associated aplastic anaemia: the first case of its kind. J Clin Virol 2012; 54:96-97.
46. Dumoulin FL, Liese H. Acute hepatitis E virus infection and autoimmune thyroiditis: yet another trigger? BMJ Case Rep 2012; pii: bcr1220115441. doi:10.1136/bcr.12.2011.5441.
47. Kamar N, Weclawiak H, Guilbeau-Frugier C, et al. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 2012; 93:617-623.
48. Kamar N, Bendall RP, Peron JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011; 17:173-179.
49. Maurissen I, Jeurissen A, Strauven T, et al. First case of antiganglioside GM1-positive Guillain-Barré syndrome due to hepatitis E virus infection. Infection 2012; 40:323-326.
50. Ijaz S, Szypulska R, Tettmar K, et al. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang 2012; 102:272.
51. Baylis SA, Gä rtner T, Nick S, et al. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox San 2012; 103:89-90.
52. Vollmer T, Diekmann J, Johne R, et al. Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol 2012; 50:2708-2713.
53. Goyal R, Kumar A, Panda SK, et al. Ribavirin therapy for hepatitis E virusinduced acute on chronic liver failure: a preliminary report. Antivir Ther 2012; 17:1091-1096.
54. Pé ron JM, Dalton H, Izopet J, Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol 2011; 54:1323-1324.
55. Pischke S, Hardtke D, Bode U, et al. Ribavirin treatment of acute and chronic hepatitis E: a single centre experience. Liver Int 2013; 33:722-726.
56. Jagjit Singh GK, Ijaz S, Rockwood N, et al. Chronic hepatitis E as a cause for cryptogenic cirrhosis in HIV. J Infect 2013; 66:103-106.
57. Andersson MI, Preiser W, Tongani G, et al. Immune reconstitution hepatitis E: a neglected complication of antiretroviral therapy in Africa? AIDS 2013; 27:487-492.
58. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376:895-902.